Literature DB >> 26415829

Mannan-decorated thiolated Eudragit microspheres for targeting antigen presenting cells via nasal vaccination.

Hui-Shan Li1, Bijay Singh1, Tae-Eun Park1, Zhong-Shan Hong2, Sang-Kee Kang3, Chong-Su Cho4, Yun-Jaie Choi5.   

Abstract

Mucosal vaccination of protein as an antigen requires appropriate delivery or adjuvant systems to deliver antigen to mucosal immune cells efficiently and generate valid immune responses. For successful nasal immunization, the obstacles imposed by the normal process of mucociliary clearance which limits residence time of applied antigens and low antigen delivery to antigen presenting cells (APCs) in nasal associated lymphoid tissue (NALT) need to be overcome for the efficient vaccination. Here, we prepared mucoadhesive and mannan-decorated thiolated Eudragit microspheres (Man-TEM) as a nasal vaccine carrier to overcome the limitations. Mucoadhesive thiolated Eudragit (TE) were decorated with mannan for targeting mannose receptors (MR) in antigen presenting cells (APCs) to obtain efficient immune responses. The potential adjuvant ability of Man-TEM for intranasal immunization was confirmed by in vitro and in vivo experiments. In mechanistic study using APCs in vitro, we obtained that Man-TEM enhanced the receptor-mediated endocytosis by stimulating the MR receptors of APCs. The nasal vaccination of OVA-loaded Man-TEM in mice showed higher levels of serum IgG and mucosal sIgA than the soluble OVA group due to the specific recognition of MR of APCs by the mannan in the Man-TEM. These results suggest that mucoadhesive and Man-TEM may be a promising candidate for nasal vaccine delivery system to elicit systemic and mucosal immunity.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adjuvant; Antigen presenting cells (APCs); Mannan; Mannose receptor targeting; Mucoadhesive microspheres; Nasal vaccine

Mesh:

Substances:

Year:  2015        PMID: 26415829     DOI: 10.1016/j.ejps.2015.09.014

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  6 in total

1.  Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of Pseudomonas sinusitis.

Authors:  Dong-Jin Lim; Justin McCormick; Daniel Skinner; Shaoyan Zhang; Jeffrey B Elder; John G McLemore; Mark Allen; John Martin West; Jessica W Grayson; Steven M Rowe; Bradford A Woodworth; Do-Yeon Cho
Journal:  Int Forum Allergy Rhinol       Date:  2019-12-23       Impact factor: 3.858

2.  In-vitro evaluation of a ciprofloxacin and azithromycin sinus stent for Pseudomonas aeruginosa biofilms.

Authors:  Dong-Jin Lim; Daniel Skinner; John Mclemore; Nick Rivers; Jeffrey Brent Elder; Mark Allen; Connor Koch; John West; Shaoyan Zhang; Harrison M Thompson; Justin P McCormick; Jessica W Grayson; Do-Yeon Cho; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-11-06       Impact factor: 3.858

3.  In-vitro evaluation of a ciprofloxacin- and ivacaftor-coated sinus stent against Pseudomonas aeruginosa biofilms.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Christopher G Weeks; Jaime A Peña Garcia; Daniel Skinner; Shaoyan Zhang; Justin McCormick; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2019-01-31       Impact factor: 3.858

4.  Glycan recognition by human blood mononuclear cells with an emphasis on dendritic cells.

Authors:  Eugenia M Rapoport; Sergey V Khaidukov; Andrey M Gaponov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Panagiota Milona; Nicolai V Bovin; Kenneth C McCullough
Journal:  Glycoconj J       Date:  2018-01-31       Impact factor: 2.916

Review 5.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

Review 6.  Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems.

Authors:  Chong-Su Cho; Soo-Kyung Hwang; Min-Jeong Gu; Cheol-Gyun Kim; Seo-Kyung Kim; Do-Bin Ju; Cheol-Heui Yun; Hyun-Joong Kim
Journal:  Tissue Eng Regen Med       Date:  2021-07-25       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.